ALR Share Price

Open 49.46 Change Price %
High 49.70 1 Day 0.12 0.24
Low 49.39 1 Week -0.06 -0.12
Close 49.56 1 Month -0.91 -1.80
Volume 577119 1 Year 9.05 22.34
52 Week High 50.63
52 Week Low 34.41
ALR Important Levels
Resistance 2 49.85
Resistance 1 49.73
Pivot 49.55
Support 1 49.39
Support 2 49.27
NYSE USA Most Active Stocks
RAI 65.40 -2.23%
RAI 65.40 -2.23%
EMC 29.05 0.97%
EMC 29.05 0.97%
EMC 29.05 0.97%
SE 40.68 -0.78%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
BAC 23.83 1.92%
More..
NYSE USA Top Gainers Stocks
EBR 6.61 48.54%
POM 26.93 26.79%
POM 26.93 26.79%
GLF 0.34 25.93%
GLF 0.34 25.93%
DSW 18.43 17.46%
RT 2.11 14.67%
FNP 35.24 12.02%
FNP 35.24 12.02%
BBX 7.06 11.53%
More..
NYSE USA Top Losers Stocks
ENL 15.81 -66.25%
ENL 15.81 -66.25%
ENL 15.81 -66.25%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
More..

Alere Inc. (NYSE: ALR)

ALR Technical Analysis 2
As on 22nd Aug 2017 ALR Share Price closed @ 49.56 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 43.73 & Sell for SHORT-TERM with Stoploss of 50.07 we also expect STOCK to react on Following IMPORTANT LEVELS.
ALR Target for August
1st Target up-side 50.64
2nd Target up-side 50.82
3rd Target up-side 50.99
1st Target down-side 50.14
2nd Target down-side 49.96
3rd Target down-side 49.79
ALR Other Details
Segment EQ
Market Capital 1603132288.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.alere.com
ALR Address
ALR
51 Sawyer Road
Suite 200
Waltham, MA 02453
United States
Phone: 781-647-3900
ALR Latest News
Interactive Technical Analysis Chart Alere Inc. ( ALR NYSE USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Alere Inc.
ALR Business Profile
Alere Inc. provides diagnostics and services for cardiology, infectious disease, toxicology, and diabetes in the United States and internationally. The company operates in three segments: Professional Diagnostics, Health Information Solutions, and Consumer Diagnostics. The Professional Diagnostics segment provides diagnostic test products and other in vitro diagnostic tests to medical professionals and laboratories for detection of diseases and conditions in the areas of cardiology, infectious diseases, toxicology, diabetes, oncology, and women’s health, as well as offers connected device technologies. The Health Information Solutions segment offers integrated programs and services focused on wellness, disease and condition management, productivity enhancement, and informatics. This segment’s health improvement programs comprise patient self-testing, condition and case management, women’s and children’s health, and health and wellness programs. The Consumer Diagnostics segment provides products for over-the-counter pregnancy and fertility/ovulation test markets; and over-the-counter drug tests for at-home testing and cholesterol monitoring under the First Check brand name, as well as vaginal gel for the treatment of bacterial vaginosis. Alere Inc. markets its professional diagnostic products to hospitals, reference laboratories, physician offices, and other point-of-care settings through its sales force and distribution networks; health information solutions primarily to commercial and governmental health plans, self-insured employers, government and governmental programs, pharmaceutical companies, and physicians through sales force and channel partners; and consumer drug testing products through retail drug stores, drug wholesalers, groceries, and mass merchandisers. The company was formerly known as Inverness Medical Innovations, Inc. and changed its name to Alere Inc. in July 2010. Alere Inc. was founded in 2001 and is headquartered in Waltham, Massachusetts.